Everyday Health (EVDY) Says Sales Execution Problems Affected Consumer Segment; Leerink Partners Reiterates Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- Tesla acquires AI hardware company for up to $2 billion in stock
Everyday Health and Videology Partner to Launch TVRx, the Industry's Most Comprehensive Data-Driven Video Solution for Pharma Advertisers
November 10, 2015 4:01 PM ESTNEW YORK, Nov. 10, 2015 /PRNewswire/ --Â Everyday Health, Inc. (NYSE: EVDY), a leading provider of digital health marketing and communications solutions, and Videology, a leading software provider for converged TV and video advertising, today announced the launch of TVRx, a solution for pharmaceutical and health-oriented marketers to target relevant health audiences across television and digital video. The innovative partnership combines Everyday Health's extensive audience... More
Everyday Health Reports Third Quarter 2015 Financial Results
November 10, 2015 4:01 PM ESTNEW YORK, Nov. 10, 2015 /PRNewswire/ --Â Everyday Health, Inc. (NYSE: EVDY), a leading provider of digital health marketing and communications solutions, today announced financial results for the third quarter ended September 30, 2015.
For the third quarter:
Total revenue grew 28% year-over-year. Advertising and sponsorship revenue grew 31% year-over-year. Average revenue per top 30 strategic advertiser increased 43% year-over-year. Pharma revenue grew 36% year-over-year. Cash flow from operations grew 29% year-over-year."In... More

